Spirulina and the Methylation Cycle

The Methionine-Homocysteine Cycle

Methionine is converted to S-adenosylmethionine (SAM, the universal methyl donor) by MAT. SAM donates methyl groups to substrates via methyltransferases (PRMTs, DNMTs, histone methyltransferases, COMT), generating SAH. SAH is hydrolyzed to homocysteine, which is either remethylated to methionine (via MTR using B12 + methylfolate from MTHFR) or transsulfurated to cysteine (via CBS using B6).

MTHFR and Folate

5,10-methylenetetrahydrofolate reductase (MTHFR) reduces methylenetetrahydrofolate to methyltetrahydrofolate — substrate for homocysteine remethylation. MTHFR C677T polymorphism (40-50% population prevalence as heterozygous) reduces enzyme activity by 30-65%, elevating homocysteine. Spirulina's folate content (~50-100 μg/100g) supplements dietary folate; phycocyanin's reduced oxidative stress preserves MTHFR activity.

B12 and Methylation

Cobalamin (B12) is cofactor for methionine synthase (MTR). B12 deficiency elevates homocysteine and impairs methylation broadly. Spirulina contains B12 analogs that are largely biologically inactive in humans — supplementation should not rely on spirulina for B12. However, spirulina's other methylation-supportive nutrients and inflammation reduction help when B12 status is otherwise adequate.

Hyperhomocysteinemia

Elevated homocysteine drives cardiovascular disease, cognitive decline, and pregnancy complications. Inflammation impairs methylation (NF-κB-driven CBS suppression). Spirulina's anti-inflammatory effects reduce homocysteine by 10-20% in interventional studies, with folate provision contributing.

Conclusion

Spirulina supports methylation through folate provision, reduced oxidative damage to MTHFR and methylation enzymes, and inflammation reduction permitting normal cycle flux. Direct B12 contribution remains negligible (use proper B12 supplementation separately). Quantified effect: 10-20% homocysteine reduction in elevated baseline populations.